American Century Small Cap Growth Insights ETF
ACSG - ETF AI Analysis
Top Page
American Century Small Cap Growth Insights ETF (ACSG)
ACSG, the American Century Small Cap Growth Insights ETF, appears to offer solid but not outstanding quality, driven by several strong growth-focused holdings like Krystal Biotech, which benefits from successful international expansion and robust earnings, and Hexcel, which adds stability through strong cash flow management and bullish momentum. However, some holdings such as Radnet and Sensient Technologies face profitability, cash flow, and bearish technical challenges, which likely weigh on the fund’s overall rating. A key risk factor is that many top positions show signs of high valuation or overbought conditions, meaning investors should be mindful of potential volatility and downside if growth expectations are not met.
ACSG vs. SPDR S&P 500 ETF (SPY)
- AUM
- 53.97M
- Region
- North America
- Expense Ratio
- 0.49%
- Beta
- 1.20
- Issuer
- American Century
- Inception Date
- Oct 14, 2025
- Dividend Yield
- 5.33%
- Asset Class
- Equity
- Index Tracked
- No Underlying Index
ACSG Summary
American Century Small Cap Growth Insights ETF (ACSG) is an actively managed fund that focuses on smaller U.S. companies that the managers believe have strong growth potential. It doesn’t track a set index, but instead picks individual stocks, with a lot of exposure to health care, technology, and industrial businesses. Examples of companies it holds include Krystal Biotech and Hexcel. Someone might invest in ACSG to seek long-term growth and to diversify beyond large, well-known stocks. A key risk is that small-company shares can be more volatile and can go up and down more sharply than the overall market.
How much will it cost me?
This ETF has an expense ratio of 0.49%, which means you’ll pay about $4.90 per year for every $1,000 you invest. That’s higher than the average index (passive) ETF because this fund is actively managed, with managers researching and selecting small-cap growth stocks for you.
What would affect this ETF?
This ETF could benefit if the U.S. economy stays healthy, investors favor fast-growing small companies, and innovation in areas like health care and technology continues to attract money to its key sectors and top biotech and software holdings. On the other hand, it could be hurt by higher interest rates, an economic slowdown that hits small businesses harder than large ones, or regulatory and reimbursement changes that weigh on health care and biotech stocks in particular.
ACSG Top 10 Holdings
ACSG is leaning heavily into U.S. small-cap health care and tech, with names like 10x Genomics and Krystal Biotech acting as the fund’s high-octane growth engines—though their ride has been bumpy, with strong longer-term momentum but some recent lagging. Sensient Technologies has been a steady bright spot, rising and helping to anchor returns, while Agilysys adds a more mixed but still growth-oriented tech flavor. On the flip side, CECO Environmental has been losing steam, weighing on performance. Overall, this is a U.S.-focused, innovation-driven portfolio with a clear tilt toward small, fast-growing medical and technology players.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Agilysys | 0.87% | $471.95K | $3.48B | -5.39% | 73Outperform | |
| Magnite | 0.88% | $473.00K | $4.19B | 106.47% | 68Neutral | |
| Weatherford International | 0.86% | $464.75K | $6.28B | 17.88% | 72Outperform | |
| Radnet | 0.83% | $446.85K | $6.15B | 2.14% | 63Neutral | |
| Krystal Biotech | 0.81% | $437.27K | $9.15B | 50.56% | 80Outperform | |
| Life Time Group Holdings | 0.80% | $434.00K | $10.67B | 75.69% | 71Outperform | |
| Hexcel | 0.77% | $415.31K | $6.17B | 16.27% | 73Outperform | |
| Herc Holdings | 0.81% | $434.58K | $5.82B | 19.39% | 67Neutral | |
| Encompass Health | 0.76% | $410.36K | $13.96B | 22.67% | 64Neutral | |
| Sensient Technologies | 0.73% | $392.67K | $5.06B | 22.33% | 63Neutral |
ACSG Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For ACSG, the sentiment is Positive. The current price of 46.07 is above the 20-day moving average (MA) of 45.65, below the 50-day MA of 46.24, and above the 200-day MA of 45.62, indicating a neutral trend. The MACD of 0.00 indicates Negative momentum. The RSI at 50.52 is Neutral, neither overbought nor oversold. The STOCH value of 78.49 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for ACSG.
ACSG Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| $46.07 | $49.00(6.36% Upside) | $53.97M | 0.49% | 64Neutral | |
| $34.43 | $43.46(26.25% Upside) | $52.83M | 0.85% | 63Neutral | |
| $26.34 | $33.64(27.73% Upside) | $52.26M | 0.95% | 63Neutral | |
| $24.81 | $35.00(41.05% Upside) | $28.54M | 0.80% | 60Neutral | |
| $25.92 | $35.99(38.88% Upside) | $7.80M | 0.28% | 62Neutral | |
| $22.12 | $26.50(19.85% Upside) | $6.87M | 0.55% | 68Neutral |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| ACSG | American Century Small Cap Growth Insights ETF | 46.07 | 6.60 | 16.73% | |
| TMFS | Motley Fool Small-Cap Growth ETF | 34.43 | 0.92 | 2.74% | |
| MMSC | First Trust Multi-Manager Small Cap Opportunities ETF | 26.34 | 3.40 | 14.82% | |
| SGRW | Harbor Active Small Cap Growth ETF | 24.81 | 4.52 | 22.28% | |
| FSEG | Fidelity Enhanced Small Cap Growth ETF | 25.91 | 0.69 | 2.72% | |
| SAWS | AAM Sawgrass US Small Cap Quality Growth ETF | 22.11 | 1.61 | 7.86% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
